Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia

Figure 3

Time to first treatment (a) and overall survival (b) according to serum sTACI.

(a)

(b)